1. AstraZeneca, Lilly, Sanofi, and others raise prices to start July — Merck gets a CRL from FDA on Keytruda for hepatocellular carcinoma — 2020 biotech IPOs continue to break records — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Accountable Care Organization

Discussion in 'Pinnacle Biologics' started by Anonymous, Jun 4, 2013 at 8:17 AM.

Tags: Add Tags

  1. Anonymous

    Anonymous Guest

    This is gaining lots of traction. Today, I was told by a KOL that the ACO model which is being implemented across ALL health systems will put the nail in the coffin for costly procedures such as PDT. Yesterday, the ACO model was thoroughly discussed at a multiple health system conference. Photofrin was on a list of examples for costly non-survival procedures.